MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CNSP — CNS Pharmaceuticals, Inc. Common Stock
NasdaqCNS Pharmaceuticals, Inc. Common Stock
$5.32
+0.08(+1.61%)
- O
- 5.23
- H
- 5.40
- L
- 5.11
- V
- 10.9K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About CNSP
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateNov 8, 2019
Employees8
Stock ExchangeNasdaq
Ticker SymbolCNSP
Websitehttps://www.cnspharma.com
Key Financial Statistics
| Market Cap | $7.21M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $1.90 - $10.59 |
| 52-Week Avg Volume | 373.5K |
| VWAP | $5.28 |
| Transactions | 265 |
| Total Recorded Bars | 1,732 days |